Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Life events or new priorities often require tweaks; identify triggers and implement targeted changes to keep your finances on track.
19,621 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Micron Technology has sprinted to the high end of a price landscape after surging 814% year. As investors weigh the n...
Institutional moves can reshape a niche tech stock overnight. This article breaks down the recent liquidation by Loun...
Retirees aiming for $10,000 a month at 65 face a tight budget once taxes, Medicare premiums, and rising costs are app...
Bitcoin trades below $65k, yet Polymarket participants are betting on a $150k price by year-end 2026. This article ex...
A dramatic streaming deal sparks a rally in Paramount Skydance and reshapes the media landscape. This guide breaks do...
Investors wonder if a stock market crash coming in 2026 is on the horizon. This guide breaks down the data, compares ...
A volatile market mood meets a high-stakes regulatory backdrop. This guide unpacks how to evaluate the latest super m...
Investors woke up to news that rocket stock dropped today, sending shares of Rocket Lab into the spotlight. This arti...
In Q1 2026, Bitcoin faced the sharpest miner exodus on record, with miners selling BTC and redirecting billions to AI...
Apple just shifted pricing across its lineup, signaling a strategic move that could impact margins and demand. This g...
Rumors swirl about a $60.50 per share bid for PayPal by Stripe and Advent, with Block joining the mix. The real prize...